Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation

Showkat A Haji, Randall C Starling, Robin K Avery, Steven Mawhorter, E.Murat Tuzcu, Paul Schoenhagen, Daniel J Cook, Norman B Ratliff, Patrick M McCarthy, James B Young, Mohamad H Yamani
  • The Journal of Heart and Lung Transplantation, March 2004, Elsevier
  • DOI: 10.1016/s1053-2498(03)00148-7

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Paul ` Schoenhagen and Paul Schoenhagen